InspireMD (NSPR) Shares Outstanding (Diluted Average) (2022 - 2025)
InspireMD (NSPR) reported Shares Outstanding (Diluted Average) of $64.3 million for Q4 2025, up 53.42% on a YoY basis from $41.9 million in Q4 2024, and down 12.44% quarter-over-quarter from $73.5 million in Q3 2025.
InspireMD (NSPR) Shares Outstanding (Diluted Average) (2022 - 2025) Analysis & Trends
InspireMD has reported Shares Outstanding (Diluted Average) for 4 years, with the latest figure at $64.3 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 53.42% year-over-year to $64.3 million; the trailing twelve-month figure through Dec 2025 stood at $64.3 million (up 53.42% YoY), and the FY2025 full-year result was $64.3 million, up 53.42% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $64.3 million, down from $73.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $73.5 million in Q3 2025, with the low at $7.8 million in Q2 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $32.6 million across 4 years, with a median of $34.2 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) surged 323.1% — and 2025, when it surged 44.06%.
- InspireMD's Shares Outstanding (Diluted Average) stood at $7.9 million in 2022, then surged by 208.29% to $24.3 million in 2023, then surged by 72.77% to $41.9 million in 2024, then soared by 53.42% to $64.3 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $64.3 million (Q4 2025), $73.5 million (Q3 2025), and $50.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn | 64.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.33 Mn |
| Sep 30, 2025 | 73.47 Mn |
| Jun 30, 2025 | 50.51 Mn |
| Mar 31, 2025 | 49.99 Mn |
| Dec 31, 2024 | 41.93 Mn |
| Sep 30, 2024 | 48.37 Mn |
| Jun 30, 2024 | 35.06 Mn |
| Mar 31, 2024 | 34.24 Mn |
| Dec 31, 2023 | 24.27 Mn |
| Sep 30, 2023 | 21.15 Mn |
| Jun 30, 2023 | 14.62 Mn |
| Mar 31, 2023 | 8.09 Mn |
| Dec 31, 2022 | 7.87 Mn |
| Sep 30, 2022 | 7.82 Mn |
| Jun 30, 2022 | 7.81 Mn |